• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Q2 sales, net losses grow for Exact Sciences

Q2 sales, net losses grow for Exact Sciences

August 14, 2009 By MassDevice staff

Exact Sciences Corp. got big sales boost during the second quarter, but net losses still widened as the colorectal cancer screening firm settling into its new digs in Wisconsin and started paying the vig on a licensing deal with the Mayo Clinic.

Madison, Wis.-based Exact Sciences posted a net loss of $2.4 million on sales of $1.3 million during the three months ended June 30, compared with a net loss of $2.1 million on negative revenues of $146,000 during the same period last year.

The company, which got a $1 million loan in June from the Badger State to fund its move from Marlborough, Mass., to Madison, said the sales boost was due to a $17.2 million deal it struck in January with Genzyme Corp.

Exact Sciences said operating expenses rose 83 percent to $3.7 million for the quarter, compared with $2 million during Q2 2008.

That’s largely due to a $1.7-million non-cash charge incurred as part of Exact Science’s licensing deal with the Mayo Clinic for the rights to market a non-invasive, stool-based DNA screen for colorectal cancer the company hopes to bring to market.

Exact ended the period with $27.8 million in cash, cash equivalents and marketable securities, up from $4.9 million as of Dec. 31, 2008, largely on a $8.2 million private stock placement it executed in June.

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics

More recent news

  • Neuronetics names Steven Pfanstiel chief financial officer
  • Medtronic to distribute Future Medical’s peripheral guidewires
  • AtriCure completes enrollment in stroke prevention trial
  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy